Kevin Robert Lind

Insider Reports History

Location
C/O Arena Pharmaceuticals, Inc., 6154 Nancy Ridge Drive, San Diego, CA
Signature
/s/ Donald R. Reynolds, by Power of Attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kevin Robert Lind:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Longboard Pharmaceuticals, Inc. President and CEO, Director Common Stock 0 $0 $60.00 Dec 2, 2024 Direct
Longboard Pharmaceuticals, Inc. President and CEO, Director Stock Option (Right to Buy) 255K Nov 13, 2024 Direct
Avalo Therapeutics, Inc. Director Stock Option (Right to Buy) 40.2K Oct 1, 2025 Direct
Longboard Pharmaceuticals, Inc. President and CEO, Director Retention Restricted Stock Units 22K Oct 25, 2024 Direct
Longboard Pharmaceuticals, Inc. President and CEO, Director Employee Stock Option (right to buy) 0 Dec 2, 2024 Direct
Longboard Pharmaceuticals, Inc. President and CEO, Director Restricted Stock Unit 0 Dec 2, 2024 Direct

Insider Reports Filed by Kevin Robert Lind

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AVTX Avalo Therapeutics, Inc. Oct 1, 2025 1 $0 4 Oct 2, 2025 Director
AVTX Avalo Therapeutics, Inc. Oct 1, 2025 0 $0 3 Oct 2, 2025 Director
LBPH Longboard Pharmaceuticals, Inc. Dec 2, 2024 6 -$21.8M 4 Dec 2, 2024 President and CEO, Director
LBPH Longboard Pharmaceuticals, Inc. Nov 13, 2024 3 $40K 4 Nov 13, 2024 CEO, Director
LBPH Longboard Pharmaceuticals, Inc. Oct 25, 2024 1 $0 4 Oct 29, 2024 CEO, Director
LBPH Longboard Pharmaceuticals, Inc. Aug 12, 2024 4 $260K 4 Aug 13, 2024 CEO, Director
LBPH Longboard Pharmaceuticals, Inc. Feb 8, 2024 1 $0 4 Feb 9, 2024 CEO, Director
LBPH Longboard Pharmaceuticals, Inc. Feb 9, 2023 1 $0 4 Feb 10, 2023 CEO, Director
LBPH Longboard Pharmaceuticals, Inc. Feb 9, 2022 1 $0 4 Feb 11, 2022 CEO, Director